Objective: The role of inflammation in structural and symptomatic osteoarthritis (OA) remains unclear. One key mediator of inflammation is the chemokine CCL2, primarily responsible for attracting monocytes to sites of injury. We investigated the role of CCL2 and its receptor CCR2 in experimental OA. Design: OA was induced in 10 weeks old male wild type (WT), Ccl2 À/À and Ccr2 À/À mice, by destabilisation of the medial meniscus (DMM). RNA was extracted from whole joints at 6 h and 7 days postsurgery and examined by reverse transcription polymerase chain reaction (RT-PCR). Gene expression changes between naïve and DMM-operated mice were compared. Chondropathy scores, from mice at 8, 12, 16 and 20 weeks post DMM were calculated using modified Osteoarthritis Research Society International (OARSI) grading systems. Changes in hind paw weight distribution, as a measure of pain, were assessed by Linton incapacitance. Results: Absence of CCL2 strongly suppressed (>90%) selective inflammatory response genes in the joint 6 h post DMM, including arginase 1, prostaglandin synthase 2, nitric oxide synthase 2 and inhibin A. IL6, MMP3 and tissue inhibitor of metalloproteinase 1 were also significantly suppressed. Similar trends were also observed in the absence of CCR2. A lower average chondropathy score was observed in both Ccl2
Introduction
Although osteoarthritis (OA) is described as a non-inflammatory form of arthritis, it is frequently associated with low-grade synovitis and modestly elevated levels of inflammatory cytokines, systemically and within the synovial fluid 1, 2 . The role of inflammation in the structural and symptomatic course of disease is debated. Whilst cartilage degradation is induced readily in vitro following stimulation with inflammatory cytokines such as IL1, IL6 and TNF, these cytokines do not appear to have a major role in vivo in joint destabilisation models of OA, although not all studies agree 3e7 . The chemokine CCL2, also referred to as monocyte chemotactic protein 1 (MCP1), is a key chemo-attractant molecule that binds to the cell surface leucocyte receptor CCR2. It recruits principally monocytes and to a lesser extent, memory T cells and dendritic cells to sites of inflammation. CCL2 is expressed in the synovial sublining cells of OA joints, and has been found in synovial fluid of OA knee joints 8, 9 and following acute traumatic injury 10, 11 . Ccl2 is strongly and rapidly (<6 h) induced in whole joints upon surgical joint destabilisation in the mouse 12 . Ccl2 is also induced in rat cartilage upon surgical destabilisation 13 and in vitro upon mechanical injury of cartilage 14 . The principal role of CCL2 in the joint may be to recruit leucocytes following joint injury. However, this role is unlikely to be the case in cartilage, an essentially avascular tissue, where several other mechanisms for chemokine action have been proposed 15, 16 . CCR2 is expressed by sensory neurons, and ligation by CCL2 can directly excite nociceptive neurons, thereby contributing to pain 17 . Neuronal CCR2 is regulated transiently in the dorsal root ganglia 8 weeks following surgical joint destabilisation in animal models, where it is also associated with infiltration of macrophages, a potential source of algogenic molecules, and persistence of pain. In the absence of CCR2, there was transient distal mechanical allodynia (assessed by von Frey filaments) following destabilisation of the medial meniscus (DMM), but no development of motion-induced painful behaviour 18 . The Miller study also demonstrated that chondropathy scores in the Ccr2 À/À animals at 8 weeks post destabilisation were similar to those in wild type (WT) animals 18 . In another study, using incapacitance testing, where asymmetrical hind limb weight bearing is used as a surrogate measure of pain, we reported development of painful behaviour in WT animals between 10 and 12 weeks post joint destabilisation 19 . At this time, no regulation of Ccl2 or Ccr2 was detected in joint extracts or dorsal root ganglia of animals displaying pain-related behaviour. Nor was there up-regulation of other genes associated with an inflammatory response such as CD68, CD14, IL1, COX2 ( 20 and unpublished data).
Our hypothesis is that CCL2, acting through CCR2, contributes to structural and symptomatic disease in a murine model of OA. In the present study, we have performed a comprehensive analysis of the disease course in Ccl2 À/À and Ccr2 À/À mice at several time points post DMM. We show histological cartilage damage scores from the joints at these points, measure the acute inflammatory response in the joint over the first 7 days of surgery in knockout and WT animals, and examine pain-related behaviour responses in these groups over time.
Methods

Animals
Mice were kept in approved animal care facilities (individually ventilated cages and maintained under a 12-h light/dark cycle at an ambient temperature of 21 C) and were housed 4e6 per cage. The mice were fed a certified mouse diet (RM3; Special Diet Services) and water ad libitum. Animal experiments were performed following local ethics and statutory approval. Ccr2 À/À and Ccl2 À/À mice on a C57Bl/6J background were obtained from Jackson Laboratories (USA). Both colonies were maintained as homozygote breeding pairs. C57Bl/6J mice were used as controls and were purchased from Charles Rivers, UK.
Surgical joint destabilization
Surgical joint destabilization was performed by DMM, in male mice at 10 weeks of age as previously described 21 (total numbers of mice used: À/À mice. These joints were processed and cartilage degeneration in the medial compartment was assessed histologically, as previously described 22 .
RNA extraction and reverse transcription polymerase chain reaction (RT-PCR) for whole joints
Mice were sacrificed 6 h or 7 days after surgery, the skin and muscle were removed as previously described 12 and the joints snap frozen in liquid N 2 and stored at À80 C. The frozen joints were transferred to a prechilled biopulveriser in liquid N 2 and pulverised to a fine powder. RNA from the pulverised tissue was extracted using 1 ml Trizol (ThermoFisher Scientific, UK) as previously described 12, 20 . 1 mg of total RNA was reverse transcribed using the High Capacity cDNA Reversion Transcription kit (ThermoFisher Scientific, UK) according to the manufacturer's protocol. The cDNA library was interrogated by qPCR on custom designed Taqman Low Density Array microfluidic cards (ThermoFisher Scientific, UK) on a ViiA7 thermocycler (ThermoFisher Scientific, UK). The Taqman probes used for each gene and the accession numbers for the analysed genes are listed in the Supplementary Data (Table S1 ). All TaqMan Low Density Arrays (TLDAs) were analysed together and C t values extracted using the Expression Suit Software v 1.03 (ThermoFisher Scientific, UK). Fold changes for each gene were calculated using the DDC t method, employing the 40S ribosomal protein S18 (RPS18) gene as an endogenous control and using the average of the control DC t values for each experiment as a normalizer.
Pain-related behaviour assessments
Measurements of pain-related behaviour, as described previously were obtained twice weekly for the first week then at weekly intervals after DMM or sham surgery, by Linton incapacitance testing 19, 23 . The assessor was blinded with regard to treatment (sham or DMM) (but not genotype). Pain-related behaviour was judged to be meaningful when mean values dropped below 70% weight borne through the operated compared with non-operated joint. Statistical significance was determined by comparison of measurements with the sham-operated control.
Statistical analysis
All groups of data were assessed for approximation to the Gaussian distribution using the D'Agostino and Pearson omnibus test of normality 24 . Distributions were considered to be Gaussian if the P value for the null hypothesis was greater than 0.05. When multiple comparisons between multiple end points were performed, the Bonferroni post hoc test was used to adjust for multiplicity 25 . GraphPad Prism version 6 was used for statistical analysis. To derive the sample size we performed power calculations based on previous data in WT mice 8 weeks post DMM 26 . Initial experiments were powered to detect a 50% change in chondropathy score (6 points), based on a standard deviation of 6.7, with 90% power and a set at 0.05. This gave 16 mice (eight in each group). Further animals were added subsequently to increase the power to detect a smaller difference between groups (see discussion for further details).
Results
Altered inflammatory responses in the joints of Ccl2
À/À and Ccr2
We first examined the functional effect of CCL2 or CCR2 deletion by comparing gene expression profiles of whole joints at 6 h and 7 days post surgical destabilisation. Several inflammatory response genes were strongly induced within 6 h of joint destabilisation (Table I ). These included arginase 1 (Arg1), nitric oxide synthase (Nos2), Ccl2, IL6, Ptgs2 (Cox2), TNF-stimulated gene 6 (Tsg6) and hyaluronan synthases (Has) 1 and 2. A smaller number of these were still regulated 7 days post destabilisation; Ccl2, Nos2, Ptgs2 and Tsg6. Two macrophage/monocyte markers, Cd14 and Cd68 were examined. Cd14 was significantly raised at 6 h in WT joints. Cd68 was elevated but not significantly at this early time point.
Of the genes strongly regulated 6 h post destabilisation, a number of genes were suppressed in the Ccl2 À/À joints. Table II shows these results expressed as a ratio compared with WT levels. Those suppressed at 6 h by >90% included arginase 1, Ptgs2, Nos2 and inhibin beta A (Inhba There was no significant difference in histology scores in the sham-operated joints across genotypes (data not shown). Although there was a moderately wide distribution of scores in WT animals at all three time points post DMM there was neither a significant drift in disease severity over time, or change with operator (ANOVA, P > 0.05, for 8, 12 and 20 weeks post DMM in WT mice).
Onset of pain-related behaviour following DMM surgery is significantly delayed in Ccl2
À/À and Ccr2 À/À mice Pain-related behaviour was assessed twice weekly for the first week, then weekly by incapacitance testing, a measure of changes in hind paw weight distribution 18 . Male WT mice developed significant pain-related behaviour at 11 weeks post DMM (dropping below the 70% threshold of weight borne through the operated compared with non-operated side) [ Fig. 2(A) ]. Both Ccl2 À/À and Ccr2 À/À mice 
Discussion
The CCL2/CCR2 axis is the principal monocyte chemo-attractant pathway in humans and mice. Ccl2 is one of the most strongly regulated genes in whole joint extracts of mice after joint destabilisation and persists in the joint beyond 7 days. The RNA extracted from whole joint extracts is largely attributable to the subchondral bone, with relatively small amounts coming from synovium, articular cartilage and meniscus 27 . Nonetheless, Ccl2 is also strongly regulated in the articular cartilage in response to mechanical injury 12, 14 . Its roles in the joint are therefore likely to be varied; affecting both recruitment of monocytes and other leucocytes following destabilisation injury as well as having nonimmunological roles. CCR2 is not significantly regulated upon joint injury but is expressed by many tissues of the joint including chondrocytes (Vincent unpublished data). OA is not a classical inflammatory arthritis; inflammation is regarded as episodic and moderate, and it is debated whether synovitis contributes to the production of the pathogenic proteases (ADAMTS 5 and collagenases) that characterise disease. It is nonetheless the case that most patients with severe radiographic changes also show evidence of synovitis by magnetic resonance imaging (MRI), and synovitis probably contributes to pain in these individuals 28e30 . Our results show that deletion of CCL2 and to some extent CCR2, affects some of the inflammatory response to joint destabilisation. Even though levels of Cd68, a macrophage marker, were not significantly raised at 6 h post DMM in WT animals, there was nonetheless a significant suppression of Cd68 in Ccl2 À/À and Ccr2 À/À joints at this time point. Cd14, another macrophage marker, was elevated significantly in WT mice and was suppressed in Ccl2 À/À and Ccr2 À/À joints, albeit not significantly.
Such changes might have been more evident had we measured joint changes at 3 days post DMM, a time at which macrophage levels typically peak after tissue injury 31 . It might also have been more evident had we performed a fluorescence-activated cell sorting (FACS) type analysis on extracts of synovium/capsule using methods described by others 32 . Nonetheless, our results are consistent with unpublished observations that post-operative synovitis, assessed by histology (following destabilisation or sham surgery), peaks at around 24 h post-surgery (predominantly neutrophilic at this stage) and is largely resolved by 7e10 days. At 6 h post DMM, we were able to document a >90% reduction in Nos2, Ptgs2, Inhba and arginase 1 in Ccl2 À/À joints, and a more modest but significant suppression of several other genes including Il6, Mmp3 and Timp1. A similar profile was seen in Ccr2 À/À joints although the data set for these genes was incomplete. Conversely, several inflammatory genes, including Has1/2, Arg2 and Mmp3 showed increased joint expression at 7 days post DMM in the knockout joints. Arg1 has many putative functions; its principal role is in protein excretion through the degradation of arginine in the liver, part of the urea cycle. It is also expressed in several other tissues including macrophages where it in part defines the 'M2' phenotype 33 . In macrophages, metabolism of arginine by arginase limits the availability of arginine for nitric oxide synthesis and generates ornithine, which can promote polyamine and proline synthesis. Thus high levels of Arg1 may indicate accumulation of a subset of macrophages principally involved in resolution of inflammation and promotion of repair 34, 35 . Interestingly, we observed a reciprocal increase in Arg2 levels in both the knockout mice when Arg1 was suppressed. Unlike Arg1, Arg2 is located principally in mitochondria where it also likely plays a key role in modulating nitric oxide and proline synthesis. It has a more restricted tissue distribution and has no deleterious phenotype upon constitutive deletion 36 . Shifts in cellular metabolism have recently been implicated in changing macrophage phenotype 37 and it is interesting to speculate that deletion of Ccl2 or Ccr2 is leading to a shift in metabolic status of the cells of the joint. Il6, Mmp3, Inhba, Timp1 and Ptgs2 are all well characterised inflammatory response genes with putative roles in OA pathogenesis. Several of these have been examined in knockout studies in vivo. For example, the Ptgs 1/2 double knockout mouse did not have altered chondropathy scores following DMM 5 , whereas IL6 has a conflicting role in disease; both an increase in disease with age has been observed as well as decreased disease in experimental OA (induced by DMM) in IL6 knockout mice 6, 7 . Mmp3 knockout mice develop a small increase in disease following surgical destabilisation 4 indicating a neutral or mildly protective role in the joint.
Inhibin A is a TGFb family member and is regulated by injury in the joint and cartilage in an FGF2-dependent manner 14 . The marked suppression of Inhba in Ccl2 À/À and Ccr2 À/À joints post DMM may be largely due to its role in circulating leucocytes where it has macrophage polarizing as well as other immunoregulatory roles 38 .
As inflammation is evidently important for promoting tissue repair responses as well as matrix breakdown, the interpretation of the influence of the CCL2/CCR2 axis on joint inflammation post injury makes disease prediction very challenging. Irrespective of the balance and type of inflammation present in the joints of Ccl2 À/À and Ccr2 À/À mice, there was no consistent difference in the chondropathy score between these mice at three different time points post DMM. As we amassed significant numbers of animals in these studies, we were able to determine retrospectively that, given the standard deviation, we were powered to detect a difference of 20% between means. Our failure to do so, makes it unlikely that CCL2 or CCR2 has a clinically relevant role in structural OA development. We also included data obtained from a different laboratory in which very similar results, a small non-significant reduction in disease, were obtained. The studies performed in the Vincent lab were by different operators and took place over a long period. When considering these results together, we found that there was a higher than expected spread of disease scores in WT mice, although this did not appear to be due to drift of disease severity over time or due to differences between operators. The results, nonetheless, highlight the importance of being careful to power in vivo studies appropriately to overcome this variation. . Visualisation of the synovium from coronal sessions is less reliable and was not performed.
In agreement with previously published studies, we found that although chondropathy scores were not affected by Ccr2 deletion, there was a change in the course of pain-related behaviour following DMM. Measuring pain-related behaviour at the joint by incapacitance testing, we were able to demonstrate a 4e5 weeks delay in the onset of pain-related behaviour in both Ccl2 
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